Also trades as: 7649.T (JPX) · $vol 16M

$9.49

+0.00 (+0.00%)

OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Neutral · Power 62 · $1.8B mcap · 99M float · 0.0000% daily turnover · Short 100% of daily vol

Overview Chart Smart Money Financials Income Statement Cash Flow Balance Sheet Earnings

Analysis Technicals Weather Peers ESG Institutions Dark Pool Short Interest

Income Trends

Revenue

$1.01T +15.4% ▲

5Y CAGR: +182.2%

Gross Profit

$322.1B +17.1% ▲

5Y CAGR: +185.3%

Operating Income

$48.7B +14.4% ▲

5Y CAGR: +173.3%

Net Income

$45.1B +75.6% ▲

5Y CAGR: +196.1%

EPS (Diluted)

$248.92 +75.3% ▲

5Y CAGR: +197.4%

EBITDA

$68.9B +22.6% ▲

5Y CAGR: +9.6%

Profit Margins

Year-over-Year Growth

View Full Income Statement

Line Item	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	$5.4B	$4.9B	$744.5B	$878.0B	$1.01T
YoY Growth	-3.9%	-9.9%	+15095.9%	+17.9%	+15.4%
Cost of Revenue	$3.8B	$3.4B	$515.6B	$603.0B	$691.1B
Gross Profit	$1.7B	$1.5B	$228.8B	$275.0B	$322.1B
Gross Margin	30.6%	30.3%	30.7%	31.3%	31.8%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$1.4B	$1.3B	$192.2B	$232.5B	$273.4B
Operating Expenses	$1.4B	$1.3B	$192.2B	$232.5B	$273.4B
Operating Income	$279M	$232M	$36.6B	$42.6B	$48.7B
Operating Margin	5.1%	4.7%	4.9%	4.8%	4.8%
Interest Expense	$19M	$16M	$15M	$227M	$884M
Income Before Tax	$239M	$207M	$32.1B	$38.1B	$45.3B
Tax Expense	$70M	$67M	$10.1B	$12.4B	$195M
Net Income	$169M	$139M	$22.0B	$25.7B	$45.1B
Net Margin	3.1%	2.8%	3.0%	2.9%	4.5%
EPS (Diluted)	$0.91	$0.77	$121.46	$141.96	$248.92
EBITDA	$43.4B	$44.0B	$46.2B	$56.2B	$68.9B
Shares Outstanding	185M	181M	181M	181M	181M

Line Item	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1	FY2026 Q2	FY2026 Q3	FY2026 Q4
Revenue	$201.0B	$212.8B	$220.8B	$243.4B	$1.7B	$254.4B	$249.5B	$261.0B
Cost of Revenue	$141.0B	$147.1B	$151.1B	$163.8B	$1.2B	$174.4B	$170.7B	$174.2B
Gross Profit	$60.0B	$65.7B	$69.7B	$79.6B	$525M	$80.1B	$78.8B	$86.8B
Gross Margin	29.9%	30.9%	31.6%	32.7%	30.8%	31.5%	31.6%	33.2%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$51.4B	$54.1B	$61.2B	$65.8B	$64.6B	$459M	$68.4B	$72.3B
Operating Expenses	$51.4B	$54.1B	$61.2B	$65.8B	$448M	$67.4B	$68.4B	$72.3B
Operating Income	$8.6B	$11.7B	$8.5B	$13.8B	$76M	$12.7B	$10.4B	$14.5B
Operating Margin	4.3%	5.5%	3.8%	5.7%	4.5%	5.0%	4.2%	5.5%
Interest Expense	$0	$0	$0	$0	$0	$0	$324M	$310M
Income Before Tax	$9.2B	$10.3B	$8.9B	$9.6B	$78M	$11.1B	$10.5B	$12.4B
Tax Expense	$3.1B	$3.4B	$2.9B	$3.0B	-$70M	$3.7B	$3.5B	$3.0B
Net Income	$6.1B	$6.9B	$6.0B	$6.6B	$147M	$7.4B	$7.0B	$9.3B
Net Margin	3.0%	3.3%	2.7%	2.7%	8.6%	2.9%	2.8%	3.6%
EPS (Diluted)	$33.84	$38.33	$33.19	$36.60	$0.81	$41.00	$39.00	$51.66
EBITDA	$8.6B	$11.7B	$12.0B	$18.3B	$111M	$12.7B	$15.9B	$19.7B
Shares Outstanding	181M	181M	181M	181M	181M	181M	181M	181M

SGIPF OTC

Income Trends

Profit Margins

Year-over-Year Growth

Sign in to InsiderStreet